Enhanced FOXO1 expression as a predictor of decitabine response and prolonged survival in high-risk myelodysplastic syndrome
Elevated FOXO1 expression in high-risk MDS patients undergoing decitabine treatment enhances patient prognosis and survival.
Authors
- Nanfang Huang (ORCID: https://orcid.org/0000-0002-9156-1537)
- Sida Zhao (ORCID: https://orcid.org/0000-0002-3145-705X)
- Chunkang Chang (ORCID: https://orcid.org/0000-0001-5318-5879)
- Zhihong Liu (ORCID: https://orcid.org/0000-0001-6093-0726)
- Zheng Zhang (ORCID: https://orcid.org/0000-0002-3242-5738)
- Feng Xu (ORCID: https://orcid.org/0009-0003-2371-9579)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1080/16078454.2025.2506862
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China